Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Clinical trial NCT00467077 · TERMINATED
Trial details
- NCT number
- NCT00467077
- Sponsor
- California Cancer Consortium
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.